LEVON QASABIAN M.D NPI 1396765996

NPI Details

Levon Qasabian, M.D is a specialist in West Hollywood, CA with 37 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. Levon Qasabian, M.D NPI is 1396765996. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

8737 BEVERLY BLVD
SUITE # 203
WEST HOLLYWOOD, CA
ZIP 90048-828
Phone: (323) 525-1111
Fax: (323) 525-1100

The NPI 1396765996 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, hydromorphone, up to 4 mg (HCPCS:J1170)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Unclassified drugs (HCPCS:J3490)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Thrombin time, fibrinogen screening test, plasma (HCPCS:85670)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Fibrinogen (factor 1) activity measurement (HCPCS:85384)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Blood test, clotting time (HCPCS:85610)
• Uric acid level, blood (HCPCS:84550)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone evaluation (HCPCS:84479)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Phosphate level (HCPCS:84100)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Folic acid level, serum (HCPCS:82746)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Vitamin d-3 level (HCPCS:82306)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Ldl cholesterol level (HCPCS:83721)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Hemoglobin a1c level (HCPCS:83036)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Amylase (enzyme) level (HCPCS:82150)
• Lipase (fat enzyme) level (HCPCS:83690)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Testosterone (hormone) level, total (HCPCS:84403)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)

The enumeration date for this NPI number is 7/20/2006 and was last updated on 5/13/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.